⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30290716 | 0.70 | — | — | |
| SCHEMBL2008213 | 0.69 | — | — | |
| SCHEMBL36651 | 0.67 | — | — | |
| SCHEMBL28434975 | 0.67 | TSHR (0.42) | — | |
| SCHEMBL5694171 | 0.65 | — | — | |
| SCHEMBL21933071 | 0.65 | TSHR (0.44) | — | |
| SCHEMBL27778073 | 0.65 | — | — | |
| SCHEMBL29001883 | 0.65 | TSHR (0.36) | — | |
| SCHEMBL30290754 | 0.65 | CA2 (0.31) | — | |
| SCHEMBL10675754 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12178841-B2 | Treatment of non-cystic fibrosis bronchiectasis | ZAMBON S.P.A. (IT) | 2024-12-31 | — | — | US | claimed |
| US-20240342239-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | ZAMBON S.P.A. (IT) | 2024-10-17 | — | — | US | claimed |
| EP-4380592-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | Zambon S.p.A. (IT) | 2024-06-12 | — | — | EP | claimed |
| US-20230052317-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | ZAMBON S.P.A. (IT) | 2023-02-16 | — | — | US | claimed |
| WO-2023012280-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | ZAMBON S.P.A. (IT) | 2023-02-09 | — | — | WO | claimed |
| EP-4129322-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | Zambon S.p.A. (IT) | 2023-02-08 | — | — | EP | claimed |
| EP-1000602-B1 | COPOLYMERS FOR COSMETICS | DAIKIN IND LTD (JP) | 2010-04-07 | — | — | EP | claimed |
| US-20260098181-A1 | CROSSLINKABLE COATING SYSTEM AND COATINGS PREPARED FROM THE SAME | SWIMC LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260097045-A1 | ANTIMICROBIAL COMBINATIONS | HELPERBY THERAPEUTICS LIMITED (GB) | 2026-04-09 | — | — | US | disclosed |
| US-12594319-B2 | Pharmaceutical development | HELPERBY THERAPEUTICS LIMITED (GB) | 2026-04-07 | — | — | US | disclosed |
| US-20260071011-A1 | COMPOUND, RESIN COMPOSITION, PREPREG, RESIN FILM, METAL-CLAD LAMINATE, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | RESONAC CORP (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-3511348-B1 | ION-EXCHANGE MEMBRANE | ASTOM CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20250332572-A1 | MODIFICATION OF WOVEN MATERIALS WITH MOISTURE-SWING MOIETIES FOR CO2 CAPTURE | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2025-10-30 | — | — | US | disclosed |
| CN-109426105-B | Toner and image forming apparatus | 京瓷办公信息系统株式会社 | 2022-05-03 | — | — | CN | disclosed |
| US-11312858-B2 | Resin composition, prepreg, film including resin, metal foil including resin, metal-clad laminate, and wiring board | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| EP-3980520-A1 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | Genomatica, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-108226315-B | Analysis method for detecting polymyxin E residual quantity | 上海医药工业研究院 | 2022-04-12 | — | — | CN | disclosed |
| US-11293138-B2 | Methods for obtaining colored or chromic substrates | UNIVERSITEIT GENT (BE) | 2022-04-05 | — | — | US | disclosed |
| EP-3480283-B1 | SLIPPERINESS-IMPARTING AGENT AND SLIPPERINESS-IMPARTING METHOD | NOF CORP (JP) | 2022-02-16 | — | — | EP | disclosed |
| CN-107787230-B | Surface-modified polymer composition | 路博润先进材料公司 | 2022-01-21 | — | — | CN | disclosed |